Last Updated: Jul 17, 12:00 AM·ASX
Imagion Biosystems Ltd IBX.AX
IBX.AX Shariah Compliance
Screening Methodology: AAOIFI
As of July 2026, Imagion Biosystems Ltd is classified as not halal.
NOT HALAL
Report Source: 2024 Annual Report
Imagion Biosystems Ltd. Stock Analysis IBX.AX
Imagion Biosystems Ltd. engages in the research and development of non-radioactive and safe diagnostic imaging technology. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-06-22. The firm is developing a non-radioactive and precision diagnostic molecular imaging technology. Its principal activity consists of nanotechnology, biotechnology, cancer diagnostics and medical imaging using magnetic resonance. The company uses bio-safe magnetic nanoparticles to detect cancer and other diseases. The firm operates through Research and Development segment. Its MagSense HER2 Imaging Agent (MSH2IA) is a first-in-class molecular imaging product candidate that is intended to detect tumors more accurately than relying solely on anatomical abnormalities seen in conventional imaging. With its tumor targeting, MSH2IA produces Magnetic resonance imaging (MRI) images that are differentiable between an abnormal lymph node and a normal node in HER2 positive breast cancer patients undergoing axillary imaging. Its PrecisionMRX products include Dextran-Coated, mPEG Coated, Oleic Acid Coated and Carboxylic Acid Functionalized.
Read More Imagion Biosystems Ltd (IBX.AX) Chart
Key Statistics of Imagion Biosystems Ltd (IBX.AX)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
AUD0.01Volume
1.60MP/E Ratio (TTM)
-52 Week Range
Market Cap
6.75MAvg. Volume
912.24KDividend Yield
-Financial Metrics & Statements of Imagion Biosystems Ltd (IBX.AX)
Super Investors Invested in Imagion Biosystems Ltd (IBX.AX)
FAQ's for Imagion Biosystems Ltd (IBX.AX)
- As of July 2026, Imagion Biosystems Ltd IBX.AX is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Imagion Biosystems Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Imagion Biosystems Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Imagion Biosystems Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Imagion Biosystems Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Imagion Biosystems Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
